The urgent need for proper information and prevention on prostate cancer is pointed out by the Hellenic Urological Society (EEA) on the occasion of European Day Against prostate cancer on September 15th.
He recalls that prostate cancer is one of the most common malignancies in men worldwide and invites every man to be informed responsibly about early detection and prevention with modern diagnostic tools.
In Europeevery year, About 450,000 men are diagnosed with prostate cancer overcoming colon cancer. Every year 107,000 European men die of prostate cancer. In the European Union, prostate cancer was the third Most often diagnosed cancer, representing 12.1% of new cancers in 2022.
Overall, In the EU were recorded approximately 2.7 million. New cancer diagnoses of all types and about 1.3 million deaths. The exact items show that Prostate cancer kills more men than breast cancer kills women.
In Greece2022 were marked 7.036 New Prostate incidents ranking him first in frequency in men (19.2% of new cases). The latest available data indicate that 27,358 people live with a diagnosis of prostate cancer within five years, while mortality reaches about 2,000 people.
With these data, the President of the Hellenic Urological Society, Andreas Skolarikos, emphasizes: “Prostate cancer is a major issue of public health. The Hellenic Urological Society reaffirms its commitment to documented, personalized, early detection and equal access to patients in modern diagnosis and treatment. We invite every man to consult his urologist and families in time to support prevention. Update saves lives».
Today is the most often diagnosed cancer in men in 112 of 185 countriesand the main cause of cancer death among men in 48 countries, highlighting international inequalities in early diagnosis and care. According to the World Cancer Observatory (Global Cancer Observatory 2022), the prostate is The second most common malignancy in men after lung.
Mortality touches almost the 400,000 people in 2022while over 5 million live with a five -year diagnosis, evidence that prostate cancer remains a major cause of morbidity and mortality worldwide.
In a depth of 15 years, Lancet’s (2024) analysis of prostate cancer report that By 2040 there will be nearly 3 million new diagnoses of prostate cancer each year worldwide (ie they will be doubled at about 2.9 million), while the annual mortality is expected to increased by about 85%approaching about the 700,000 per yearwith a disproportionate burden for low and medium -income countries.
As the Hellenic Urological Society notes, from diagnosis to treatment, artificial intelligence is increasingly important as a complementary tool in the hands of science.
“In the field of diagnosis, artificial intelligence has the power to recognize pattern recognition within complex medical data, improving decision making. Either by guiding during surgery or creating three -dimensional models of multiparametric magnetic resonance imaging (Multiparametric MRI) up to 3D printing personalized for each patient who help the surgeon before surgery. Her contribution is decisive, ”says Prokar Dasgupta.
These data highlights the value of the method in patient preventive control and the need for early and effective diagnosis, as in the early stages of the disease prostate cancer is practically curable, according to the Hellenic Urological Society.